Johnson & Johnson, ViaCyte testing possible diabetes cure

Johnson & Johnson, continuing its long quest for a Type 1 diabetes cure, is joining forces with biotech company ViaCyte to speed development of the first stem cell treatment that could cure the life-threatening hormonal disorder.

They've already begun testing it in a small number of diabetic patients, a first. If it works as well in patients as it has in animals, it would amount to a cure, ending the need for frequent insulin injections and blood sugar testing.

http://www.startribune.com/johnson-johnson-viacyte-testing-possible-diabetes-cure/367617521/